No More $99 DNA Tests?

What's Hot


2 Types of Black Marks Might Vanish From Your Credit File SoonBorrow

6 Ways the Obamacare Overhaul Might Impact Your WalletInsurance

7 Dumb and Costly Moves Homebuyers MakeBorrow

This Free Software Brings Old Laptops Back to LifeMore

Obamacare Replacement Plan Gets ‘F’ Rating from Consumer ReportsFamily

Beware These 12 Common Money MistakesCredit & Debt

21 Restaurants Offering Free Food Right NowSaving Money

17 Ways to Have More Fun for Less MoneySave

House Hunters: Beware of These 6 Mortgage MistakesBorrow

30 Household Uses for Baby OilSave

25 Ways to Spend Less on FoodMore

Nearly Half of Heart-Related Deaths Linked to These 10 Foods and IngredientsFamily

5 Surprising Benefits of Exercising Outdoors in WinterFamily

10 Ways to Save When You’re Making Minimum WageSave

Boost Your Credit Score Fast With These 7 MovesCredit & Debt

7 Painless Ways to Pay Off Your Mortgage Years EarlierBorrow

The Most Sinful City in the U.S. Is … (Hint: It’s Not Vegas)Family

The True Cost of Bad CreditCredit & Debt

10 Companies With the Best 401(k) PlansGrow

This Scam Now Tops ID Theft as the No. 2 Consumer ComplaintFamily

6 Stores With Awesome Reward ProgramsFamily

6 Ways to Save More at Lowe’s and The Home DepotSave

6 Healthful Treats for Your DogFamily

New Study Ranks the Best States in the U.S.Family

Thousands of Millionaires Moving to 1 Country — and Leaving AnotherGrow

Strapped for College Costs? How to Get the Most From FAFSABorrow

6 Overlooked Ways to Save at Chick-fil-AFamily

Ask Stacy: What’s the Fastest Way to Pay Off My Mortgage?Borrow

Where to Sell Your Stuff for Top DollarAround The House

8 Ways to Get a Good Price on a Shiny New AutoCars

Ask Stacy: How Do I Start Over?Credit & Debt

Secret Cell Plans: Savings Verizon, AT&T, T-Mobile and Sprint Don’t Want You to Know AboutFamily

30 Awesome Things to Do in RetirementCollege

14 Super Smart Ways to Save on TravelSave

The Rich Prefer Modest Cars — Should You Join Them?Cars

You’ll Soon Pay More to Shop at CostcoSave

10 Ways to Save When Your Teen Starts DrivingFamily

A company that sells DNA tests for less than 100 bucks is under fire from the U.S. Food and Drug Administration.

The U.S. Food and Drug Administration is telling a company that sells cheap DNA testing to stop for now.

The company, 23andMe, is a startup that can analyze your DNA (by collecting your spit) for $99. The test is marketed as a way to trace your lineage, find relatives, and look into hereditary risk for more than 240 health conditions.

Nearly half a million people have taken 23andMe’s test in the past five years, The New York Times says.

But no more, at least for now. Last Friday, the FDA sent founder Anne Wojcicki “an unusually stern letter” warning her to end sales and marketing of the DNA test immediately, The Wall Street Journal says, after it noticed the company had begun new marketing campaigns, including TV commercials.

The letter can be read in full on the FDA website, but it basically says the FDA isn’t satisfied the test works sufficiently well, and that mistakes could be dangerous to consumers. It says, in part:

If the BRCA-related risk assessment for breast or ovarian cancer reports a false positive, it could lead a patient to undergo prophylactic surgery, chemoprevention, intensive screening, or other morbidity-inducing actions, while a false negative could result in a failure to recognize an actual risk that may exist. …

We have become aware that you have initiated new marketing campaigns, including television commercials that, together with an increasing list of indications, show that you plan to expand the [testing service’s] uses and consumer base without obtaining marketing authorization from FDA.

The company and the FDA have gone back and forth for several months, MarketWatch says, and the FDA is frustrated at 23andMe’s pace in conducting the research necessary to get its approval.

“Months after you submitted your 510(k)s [clearance forms] and more than five years after you began marketing, you still had not completed some of the studies and had not even started other studies necessary to support a marketing submission,” the FDA wrote. “It is now eleven months later, and you have yet to provide FDA with any new information about these tests.”

Some say there’s no good reason to target the company. Other companies, including deCODE Genetics, Illumina, Navigenics and Knome, also sell DNA tests, MarketWatch says. But only 23andMe, whose investors include Google and Johnson & Johnson, got a letter.

“The FDA is targeting a startup that already takes steps to accurately present results,” Bloomberg Businessweek’s Diane Brady says. “The 23andMe test offers a simple promise on the health front: clarity on your genetic makeup, linked to peer-reviewed research on correlated health risks or benefits.”

Stacy Johnson

It's not the usual blah, blah, blah

I know... every site you visit wants you to subscribe to their newsletter. But our news and advice is actually worth reading! For 25 years, I've been making people richer without making their eyes glaze over. You'll be glad you did. I guarantee it!

💰🗣📰

Read Next: Lookin’ Good! How to Get a Killer Deal on Eyeglasses

Check Out Our Hottest Deals!

We're always adding new deals and coupons that'll save you big bucks. See the deals to the right and hundreds more in our Deals section.

Click here to explore 1,972 more deals!